Sucralfate is an anti-ulcer medication used to treat acid-related stomach conditions, such as ulcers and gastroesophageal reflux disease (GERD). It is available in oral tablet and suspension forms, and is typically taken once or twice daily. While it is generally a safe and effective medication, there are some potential side effects that doctors should be aware of when prescribing it to their patients. In this article, we will discuss the hidden side effects of sucralfate and how to manage them.
The most common side effects of sucralfate include nausea, vomiting, diarrhea, constipation, headache, and dizziness. These side effects are usually mild and do not require medical attention unless they become severe or do not go away. It is important to note that these side effects are more likely to occur if the medication is taken on an empty stomach.
Less common side effects of sucralfate include stomach pain, gas, indigestion, and a metallic taste in the mouth. These side effects are usually mild and do not require medical attention unless they become severe or do not go away. It is important to note that these side effects are more likely to occur if the medication is taken on an empty stomach.
Rare side effects of sucralfate include rash, hives, itching, difficulty breathing, chest tightness, swelling of the face, lips, tongue, or throat, and hoarseness. If any of these side effects occur. It is important to note that these side effects are more likely to occur if the medication is taken on an empty stomach.
Sucralfate is a safe and effective medication for treating acid-related stomach conditions. However, it can cause side effects, including nausea, vomiting, diarrhea, constipation, headache, and dizziness. If you experience any of the rare side effects, such as rash, hives, itching, difficulty breathing, chest tightness, swelling of the face, lips, tongue, or throat, or hoarseness.
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
3.
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.
1.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
2.
Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax
3.
Cancer Rates on the Rise: What Can We Do to Stop It?
4.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
2.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation